Search Results

You are looking at 331 - 340 of 2,919 items for :

  • Refine by Access: All x
Clear All
Full access

Management of Primary Central Nervous System Lymphoma

Francois G. El Kamar and Lauren E. Abrey

outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments . J Clin Oncol 2002 ; 20 : 231 – 236 . 21 Ferreri AJ Blay JY Reni M . Prognostic scoring system for primary

Full access

Head and Neck Cancers: Advantages of Advanced Radiation Therapy and Importance of Supportive Care

Sharon Spencer

look at outcomes,” she noted at the NCCN 23rd Annual Conference, “we are seeing improvement. But we can do better.” H&N squamous cell carcinoma (HNSCC) is a heterogeneous disease, encompassing a variety of tumors that originate in the hypopharynx

Full access

Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review

Andrew S. Epstein and Eileen M. O'Reilly

pancreatic cancer Analyze recommendations for primary prophylaxis against thromboembolism among patients with pancreatic cancer Assess the best treatment for thromboembolism among patients with pancreatic cancer Evaluate outcomes improved

Full access

NCCN Task Force Report: Molecular Markers in Leukemias and Lymphomas

Jerald P. Radich, Andrew D. Zelenetz, Wing C. Chan, Carlo M. Croce, Myron S. Czuczman, Harry P. Erba, Sandra J. Horning, Jane Houldsworth, B. Douglas Smith, David S. Snyder, Hema M. Sundar, Meir Wetzler, and Jane N. Winter

with imatinib (IM) [abstract] . Blood 2008 ; 112 : Abstract 186 . 16 Kantarjian H O’Brien S Talpaz M . Outcome of patients with Philadelphia chromosome-positive chronic myelogenous leukemia post-imatinib mesylate failure . Cancer 2007

Full access

Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population

Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta

in intensity-modulated radiotherapy (RT), reduction of treatment time, and combining PORT with chemotherapy make the outcomes of delayed initiation uncertain. 17 Reasons for S-PORT delay need to be investigated to identify susceptible patients and

Full access

VATS Versus Open Surgery for Lung Cancer Resection: Moving Beyond the Incision

Aaron M. Cheng and Douglas E. Wood

quality and cancer outcomes, namely cancer staging and quality of cancer surgery. Rather than debating incisions, thoracic surgeons should be advocating for specialty care and surgical quality that assures the best short- and long-term outcomes for

Full access

NCCN Guidelines Updates: Pancreatic Cancer

Margaret A. Tempero

Panel Adds to Pancreatic Cancer Recommendations For the first time in decades, advances in diagnostics and adjuvant therapies appear to be improving outcomes in pancreatic cancer. These advances are reflected in additions to the NCCN Clinical

Full access

Updates in the Management of Myelofibrosis

Presented by: Andrew T. Kuykendall

showed that overall survival in MF may be improved in the era of ruxolitinib. 4 Compared with patients who received investigational therapy or “other” treatments, patients treated with ruxolitinib had better outcomes. Additionally, those diagnosed after

Full access

New Treatment Options for the Management of Multiple Myeloma

Shaji K. Kumar

goal of therapy is to achieve a deep response while balancing toxicity, given the improved outcome in patients achieving MRD-negative status. “We still need to learn a lot about how to use MRD testing and results in the clinic,” Dr. Kumar said

Full access

Management of Patients With Nonmetastatic Prostate Cancer

Presented by: Julio M. Pow-Sang

Although localized prostate cancer is a heterogeneous disease, certain diagnostic features—pathology, imaging, and genetic profiling—can be helpful in categorizing patients into risk groups for adverse outcomes. At the NCCN 2022 Annual Conference